Product information: Active name: LANDIOLOL HYDROCHLORIDE Brand name: RAPIBLYK Innovator name AOP ORPHAN PHARMACEUTICALS AG Approval Date: NOV 22, 2024 Therapeutic activity: LANDIOLOL HYDROCHLORIDE is indicated for the treatment of ultra-short-acting β1-selective blocking agent. It inhibits the positive chronotropic effects of catecholamine adrenaline and norepinephrine on the heart. Route of administration Powder, Intravenous Structure […]
API Flash News
Tag: adrenergic antagonist
Back To Top